Division of Critical Care, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, 247-8533, Japan.
Department of Anesthesiology and Critical Care Medicine, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-cho, Omiya-ku, Saitama-shi, Saitama, 330-8503, Japan.
Eur J Trauma Emerg Surg. 2022 Apr;48(2):981-988. doi: 10.1007/s00068-020-01575-y. Epub 2021 Jan 2.
Thoracentesis and chest tube insertion are procedures commonly performed in routine clinical practice and are considered mandatory skills for all physicians. Adverse events secondary to these procedures have been widely reported; however, epidemiology data concerning life-threatening events associated with these procedures are lacking.
We retrospectively analyzed data from the Japan Council for Quality Health Care open database regarding subject safety incidents involving thoracentesis and chest tube insertion. The adverse events extracted from the database included only events associated with thoracentesis and chest tube insertion reported between January 2010 and April 2020.
We identified 137 adverse events due to thoracentesis or chest tube insertion. Our analysis also revealed at least 15 fatal adverse events and 17 cases of left/right misalignment. Not only resident doctors but also physicians with 10 years or more of clinical experience had been mentioned in these reports. The most common complications due to adverse events were lung injury (55%), thoracic vascular injury (21%), and liver injury (10%). Surgical treatment was required for 43 (31%) of the 137 cases, and the mortality risk was significantly higher for thoracic vascular injury than for other complications (p = 0.02).
We identified at least 15 fatal adverse events and 17 cases of left/right misalignment over a 10-year period in the Japan Council for Quality Health Care open database. Our findings also suggest that care should be taken to avoid thoracic vascular injury during chest tube insertion and that immediate intervention is required should such an injury occur.
胸腔穿刺和胸腔引流管插入是常规临床实践中常见的操作,被认为是所有医生的必备技能。这些操作的不良事件已有广泛报道;然而,缺乏与这些操作相关的危及生命的事件的流行病学数据。
我们回顾性分析了日本医疗质量改善协会公开数据库中关于胸腔穿刺和胸腔引流管插入相关的不良事件的安全性数据。从数据库中提取的不良事件仅包括 2010 年 1 月至 2020 年 4 月期间报告的与胸腔穿刺和胸腔引流管插入相关的不良事件。
我们确定了 137 例胸腔穿刺或胸腔引流管插入引起的不良事件。我们的分析还揭示了至少 15 例致命不良事件和 17 例左右错位的病例。在这些报告中,不仅提到了住院医生,还提到了具有 10 年以上临床经验的医生。由于不良事件导致的最常见并发症是肺损伤(55%)、胸血管损伤(21%)和肝损伤(10%)。137 例中有 43 例(31%)需要手术治疗,胸血管损伤的死亡率明显高于其他并发症(p=0.02)。
在日本医疗质量改善协会的公开数据库中,我们在 10 年内确定了至少 15 例致命不良事件和 17 例左右错位的病例。我们的研究结果还表明,在插入胸腔引流管时应注意避免胸血管损伤,一旦发生这种损伤,应立即进行干预。